Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KCNIP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF611 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
OPCML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAREM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRYL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLCO4C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B4GALNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYL12A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRISPLD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM109 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on